Cornerstone Planning Group »

Kempharm shares owned by Cornerstone Planning Group

Quarter-by-quarter ownership of Kempharm (ZVRA) shares owned by Cornerstone Planning Group from 13F filings

Historical chart of Cornerstone Planning Group investment in Kempharm

Tip: Access up to 7 years of quarterly data

All positions including Kempharm held by Cornerstone Planning Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kempharm by Cornerstone Planning Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $6.0k 700 8.63
2025-09-30 $44 3 14.67

More positions owned by Cornerstone Planning Group

Invesco Nasdaq 100 Etf Exchange Traded Fund (QQQM)
Fidelity Enhanced International Etf Exchange Traded Fund (FENI)
Schwab Fundamental U.s. Large Company Etf Exchange Traded Fund (FNDX)
Vanguard Intermediate-term Bond Etf Exchange Traded Fund (BIV)
Ishares U.s. Smallcap Equity Factor Etf Exchange Traded Fund (SMLF)
Ishares Morningstar Mid-cap Growth Etf Exchange Traded Fund (IMCG)
Ishares Convertible Bond Etf Exchange Traded Fund (ICVT)
Invesco Qqq Trust Series I Exchange Traded Fund (QQQ)
Ishares High Yield Systematic Bond Etf Exchange Traded Fund (HYDB)
First Trust Long/short Equity Etf Exchange Traded Fund (FTLS)
Vanguard Ftse Developed Markets Etf Exchange Traded Fund (VEA)
Spdr S&p North American Natural Resources Etf Exchange Traded Fund (NANR)
Ishares Residential And Multisector Real Estate Etf Exchange Traded Fund (REZ)
Schwab Fundamental Emerging Markets Equity Etf Exchange Traded Fund (FNDE)
Victoryshares Short-term Bond Etf Exchange Traded Fund (USTB)

View all positions for Cornerstone Planning Group

Top funds holding Kempharm

BlackRock
Woodline Partners
Vanguard Group
Caption Management
Adage Capital Partners GP
Nantahala Capital Management
FMR
State Street Corporation
Geode Capital Management
Legal & General Group
Millennium Management
683 Capital Management
Royce & Associates
D. E. Shaw & Co
Marshall Wace

View all funds holding Kempharm